Skip to main content

Series A Therapeutics Companies

Explore 229 therapeutics startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
229
Total Funding
$924.9M
Avg Funding
$37.0M
Cities
19

Export 229 Series A Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Gaithersburg, United States
$75.0M
raised

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$20.0M
raised

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

Aug 2023
Series A

Founder Contacts

30,000+ verified contacts

Millbrae, United States

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$81.0M
raised

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Littleton, United States
$60.0M
raised

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 229 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Baltimore, United States
$10.0M
raised

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Yeoksamdong, South Korea
$2.3M
raised

InHandPlus is developing solutions to improve the way we take our prescribed medications.

Jul 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$8.0M
raised

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

May 2023
Series A

Founder Contacts

30,000+ verified contacts

Ann Arbor, United States
$9.2M
raised

Upkara operates as a biotechnology company that specializes in developing biopreservation technologies.

Apr 2023
Series A

Founder Contacts

30,000+ verified contacts

Los Angeles, United States
$20.0M
raised

SpectrumAi is modernizing and democratizing access to high-quality autism treatment.

Mar 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 229 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$85.0M
raised

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Mar 2023
Series A

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$52.0M
raised

Switch Therapeutics is a biotech company that develops RNAi therapies.

Mar 2023
Series A

Founder Contacts

30,000+ verified contacts

Berkeley, United States
$8.1M
raised

Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.

Feb 2023
Series A

Founder Contacts

30,000+ verified contacts

Boston, United States
$20.0M
raised

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

Feb 2023
Series A

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$200.0M
raised

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Jan 2026
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 229 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Quebec, Canada
$7.2M
raised

Find therapeutics is operator of a drug discovery and development company intended to emerge with a new therapeutic modality.

Jan 2026
Series A

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark
$20.6M
raised

Neumirna Therapeutics is a pharmaceutical company that develops therapeutics for the treatment of neurological diseases.

Jan 2025
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$50.0M
raised

Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.

Jan 2026
Series A

Founder Contacts

30,000+ verified contacts

Carver, United States
$11.5M
raised

Barologics develops disruptive technology to treat hypertension through closed-loop stimulation.

Jan 2022
Series A

Founder Contacts

30,000+ verified contacts

San Diego, United States
$50.0M
raised

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Jan 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 229 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
New York, United States

ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

Jan 2022
Series A

Founder Contacts

30,000+ verified contacts

Phoenix, United States
$60.0M
raised

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

Jan 2026
Series A

Founder Contacts

30,000+ verified contacts

Bethesda, United States
$20.0M
raised

Aradigm Health platform enables access to next generation of transformative therapies—cell and gene therapies (CGTs).

Dec 2025
Series A

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$40.0M
raised

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.

Jan 2022
Series A

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$15.0M
raised

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

Dec 2021
Series A

Founder Contacts

30,000+ verified contacts

Showing 151 to 175 of 229 companies

Ready to Connect with Series A Therapeutics Startups?

Get verified founder emails, funding details, and company data for 229 series a therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked